{"id":"https://openalex.org/W7222728552","doi":"https://doi.org/10.3389/fphar.2026.1945568","title":"Venlafaxine in oncology: supportive-care evidence and emerging preclinical anticancer signals: a systematic review","display_name":"Venlafaxine in oncology: supportive-care evidence and emerging preclinical anticancer signals: a systematic review","publication_year":2026,"publication_date":"2026-10-16","ids":{"openalex":"https://openalex.org/W7222728552","doi":"https://doi.org/10.3389/fphar.2026.1945568","pmid":"https://pubmed.ncbi.nlm.nih.gov/42964294","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13719556"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1945568","doi":"https://doi.org/10.3389/fphar.2026.1945568","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1945568","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1945568/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1945568/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5152407956","display_name":"Ahmad J. Harahsheh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157392197","display_name":"Hashemite University","ror":"https://ror.org/04a1r5z94","country_code":"JO","type":"education","lineage":["https://openalex.org/I157392197"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Ahmad J. Harahsheh","raw_affiliation_strings":["Department of Biology and Biotechnology, Faculty of Science, The Hashemite University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology and Biotechnology, Faculty of Science, The Hashemite University","institution_ids":["https://openalex.org/I157392197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5145122475","display_name":"Zhuldyz Myrzabay","orcid":"https://orcid.org/0009-0001-8730-5768","observed_orcids":["https://orcid.org/0009-0001-8730-5768"]},"institutions":[{"id":"https://openalex.org/I60559429","display_name":"Nazarbayev University","ror":"https://ror.org/052bx8q98","country_code":"KZ","type":"education","lineage":["https://openalex.org/I60559429"]}],"countries":["KZ"],"is_corresponding":false,"raw_author_name":"Zhuldyz Myrzabay","raw_affiliation_strings":["Department of Biomedical Sciences, School of Medicine, Nazarbayev University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, School of Medicine, Nazarbayev University","institution_ids":["https://openalex.org/I60559429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5145604186","display_name":"Nazym Askambayeva","orcid":"https://orcid.org/0009-0004-3462-3609","observed_orcids":["https://orcid.org/0009-0004-3462-3609"]},"institutions":[{"id":"https://openalex.org/I60559429","display_name":"Nazarbayev University","ror":"https://ror.org/052bx8q98","country_code":"KZ","type":"education","lineage":["https://openalex.org/I60559429"]}],"countries":["KZ"],"is_corresponding":false,"raw_author_name":"Nazym Askambayeva","raw_affiliation_strings":["Department of Biomedical Sciences, School of Medicine, Nazarbayev University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, School of Medicine, Nazarbayev University","institution_ids":["https://openalex.org/I60559429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158874863","display_name":"Reezal Ishak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4528857","display_name":"University of Kuala Lumpur","ror":"https://ror.org/026wwrx19","country_code":"MY","type":"education","lineage":["https://openalex.org/I4528857"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Reezal Ishak","raw_affiliation_strings":["Institute of Medical Science Technology (UniKL MESTECH), Universiti Kuala Lumpur"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medical Science Technology (UniKL MESTECH), Universiti Kuala Lumpur","institution_ids":["https://openalex.org/I4528857"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5158664849","display_name":"Mohamad Aljofan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4528857","display_name":"University of Kuala Lumpur","ror":"https://ror.org/026wwrx19","country_code":"MY","type":"education","lineage":["https://openalex.org/I4528857"]},{"id":"https://openalex.org/I60559429","display_name":"Nazarbayev University","ror":"https://ror.org/052bx8q98","country_code":"KZ","type":"education","lineage":["https://openalex.org/I60559429"]}],"countries":["KZ","MY"],"is_corresponding":true,"raw_author_name":"Mohamad Aljofan","raw_affiliation_strings":["Department of Biomedical Sciences, School of Medicine, Nazarbayev University","Institute of Medical Science Technology (UniKL MESTECH), Universiti Kuala Lumpur","National Laboratory Astana, Center for Life Sciences, Nazarbayev University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, School of Medicine, Nazarbayev University","institution_ids":["https://openalex.org/I60559429"]},{"raw_affiliation_string":"Institute of Medical Science Technology (UniKL MESTECH), Universiti Kuala Lumpur","institution_ids":["https://openalex.org/I4528857"]},{"raw_affiliation_string":"National Laboratory Astana, Center for Life Sciences, Nazarbayev University","institution_ids":["https://openalex.org/I60559429"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5158664849"],"corresponding_institution_ids":["https://openalex.org/I4528857","https://openalex.org/I60559429"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.57440046,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1945568","last_page":"1945568"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.8661999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.8661999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.06870000064373016,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.013799999840557575,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/supportive-cancer-care","display_name":"cancer supportive care","score":0.6840000152587891},{"id":"https://openalex.org/keywords/breast-cancer-survivors","display_name":"breast cancer survivors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.9750000238418579},{"id":"https://openalex.org/keywords/chemotherapy-induced-peripheral-neuropathy","display_name":"chemotherapy-induced peripheral neuropathy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/oxaliplatin-neurotoxicity","display_name":"oxaliplatin neurotoxicity","score":0.9909999966621399},{"id":"https://openalex.org/keywords/oral-mucositis","display_name":"oral mucositis","score":0.8029999732971191},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.7820000052452087},{"id":"https://openalex.org/keywords/sleep-quality","display_name":"sleep quality","score":0.9150000214576721},{"id":"https://openalex.org/keywords/depressive-symptoms","display_name":"depressive symptoms","score":0.9480000138282776},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9869999885559082},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.734000027179718},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9610000252723694},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.8942999839782715},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8159000277519226},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5605000257492065},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47999998927116394},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4742000102996826},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4147999882698059},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4050000011920929},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4025000035762787},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.37119999527931213},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3628999888896942},{"id":"https://openalex.org/C141330323","wikidata":"https://www.wikidata.org/wiki/Q2354820","display_name":"Evidence-based practice","level":3,"score":0.3612000048160553},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3361000120639801},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.3327000141143799},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32499998807907104},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.32499998807907104},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.3224000036716461},{"id":"https://openalex.org/C19648533","wikidata":"https://www.wikidata.org/wiki/Q691640","display_name":"Evidence-based medicine","level":3,"score":0.3160000145435333},{"id":"https://openalex.org/C172268261","wikidata":"https://www.wikidata.org/wiki/Q4764988","display_name":"Animal studies","level":2,"score":0.3098999857902527},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3050000071525574},{"id":"https://openalex.org/C502991105","wikidata":"https://www.wikidata.org/wiki/Q5133849","display_name":"Clinical research","level":2,"score":0.2939000129699707},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.28850001096725464},{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.2874999940395355},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.2793000042438507},{"id":"https://openalex.org/C2779901536","wikidata":"https://www.wikidata.org/wiki/Q945238","display_name":"Peripheral neuropathy","level":3,"score":0.2775000035762787},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.2766000032424927},{"id":"https://openalex.org/C148482608","wikidata":"https://www.wikidata.org/wiki/Q17007018","display_name":"Clinical study design","level":3,"score":0.2759000062942505},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.2743000090122223},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.2685000002384186},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.2578999996185303},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.2572999894618988},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.25619998574256897}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1945568","doi":"https://doi.org/10.3389/fphar.2026.1945568","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1945568","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1945568/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13719556","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13719556/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13719556/pdf/fphar-17-1945568.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42964294","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42964294","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f62751890f3243378b822f0dab410af0","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/f62751890f3243378b822f0dab410af0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1945568","doi":"https://doi.org/10.3389/fphar.2026.1945568","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1945568","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1945568/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7222728552.pdf","grobid_xml":"https://content.openalex.org/works/W7222728552.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W100004512","https://openalex.org/W1051008347","https://openalex.org/W1865738444","https://openalex.org/W2016154733","https://openalex.org/W2024652548","https://openalex.org/W2082734205","https://openalex.org/W2100963427","https://openalex.org/W2104660811","https://openalex.org/W2108000477","https://openalex.org/W2108930291","https://openalex.org/W2119945022","https://openalex.org/W2127933589","https://openalex.org/W2133675074","https://openalex.org/W2157195823","https://openalex.org/W2158681327","https://openalex.org/W2162147100","https://openalex.org/W2166564981","https://openalex.org/W2171429601","https://openalex.org/W2193066862","https://openalex.org/W2236378246","https://openalex.org/W2290466312","https://openalex.org/W2887926439","https://openalex.org/W3043680095","https://openalex.org/W4313584525","https://openalex.org/W4318678620","https://openalex.org/W4375955382","https://openalex.org/W4378211319","https://openalex.org/W4378744965","https://openalex.org/W4386273981","https://openalex.org/W4390766126","https://openalex.org/W4390946922","https://openalex.org/W4394934376","https://openalex.org/W4400337039","https://openalex.org/W4404524906","https://openalex.org/W4405854404","https://openalex.org/W4408140162","https://openalex.org/W4410871321","https://openalex.org/W4412635299","https://openalex.org/W4413783558","https://openalex.org/W7116829146","https://openalex.org/W7127898194","https://openalex.org/W7157764969"],"related_works":["https://openalex.org/W1051008347","https://openalex.org/W2597587431","https://openalex.org/W2236378246","https://openalex.org/W7132590418","https://openalex.org/W2127933589","https://openalex.org/W4234646846","https://openalex.org/W2184566509","https://openalex.org/W3080087292","https://openalex.org/W2077725247","https://openalex.org/W2394083135"],"abstract_inverted_index":{"Background:":[0],"Venlafaxine,":[1],"a":[2,105,277,303],"serotonin-norepinephrine":[3],"reuptake":[4],"inhibitor,":[5],"has":[6,309],"been":[7],"investigated":[8,257],"in":[9,49,67,88,264,314,324],"oncology":[10,316],"for":[11,19,117,127,149,179,197,206,213,222,317,352,369],"several":[12],"supportive":[13,53,224,315,328,353],"care":[14,54,225,329,354],"indications":[15,330],"and,":[16],"more":[17],"recently,":[18],"potential":[20,204],"anticancer":[21,58,258,305,334,374],"activity.":[22],"However,":[23],"the":[24,41,45,121,162],"available":[25,42],"evidence":[26,43,100,146,167,298],"remains":[27,331],"fragmented":[28],"across":[29],"clinical":[30,82,118,137,145,297,348,370],"and":[31,56,70,83,98,120,139,236,253,326,341,359],"preclinical":[32,84,99,141,339,360],"studies.":[33,129,142],"Objective:":[34],"This":[35],"systematic":[36,62],"review":[37],"aimed":[38],"to":[39,77,338],"synthesize":[40],"regarding":[44],"role":[46,313,323],"of":[47,72,124,218,238,271,285,293],"venlafaxine":[48,87,148,173,272,294,301,365],"oncology,":[50],"including":[51,227],"established":[52,311],"applications":[55],"emerging":[57],"potential.":[59],"Methods:":[60],"A":[61],"literature":[63],"search":[64],"was":[65,101,110,201,240,243],"conducted":[66],"PubMed,":[68],"Scopus,":[69],"Web":[71],"Science":[73],"from":[74],"database":[75],"inception":[76],"22":[78],"August":[79],"2026.":[80],"Original":[81],"studies":[85,119,132,138,256],"evaluating":[86],"cancer":[89,93,156,279],"populations":[90],"or":[91,215],"experimental":[92],"models":[94,266,340],"were":[95,133],"eligible.":[96],"Clinical":[97],"synthesized":[102],"separately":[103],"using":[104,112],"narrative":[106],"approach.":[107],"Methodological":[108],"quality":[109,237],"assessed":[111],"Joanna":[113],"Briggs":[114],"Institute":[115],"tools":[116],"SYRCLE":[122],"Risk":[123],"Bias":[125],"tool":[126],"animal":[128],"Results:":[130],"25":[131],"included,":[134],"comprising":[135],"23":[136],"2":[140],"The":[143],"strongest":[144,163],"supported":[147],"treatment-related":[150,318],"hot":[151,319],"flashes,":[152,320],"particularly":[153],"among":[154],"breast":[155],"survivors":[157],"receiving":[158],"endocrine":[159],"therapy,":[160],"with":[161,172,203,289],"randomized,":[164],"placebo-controlled":[165],"trial":[166],"showing":[168],"significantly":[169],"greater":[170],"reductions":[171,184],"than":[174],"placebo":[175],"(P":[176],"<":[177],"0.0001":[178],"higher":[180],"doses);":[181],"within-group":[182],"percentage":[183],"are":[185,336,350],"also":[186],"reported":[187],"but":[188,210,260],"should":[189,342],"not":[190,261],"be":[191,343,367],"interpreted":[192],"as":[193,302,372],"treatment":[194,217],"effects.":[195],"Evidence":[196,221],"chemotherapy-induced":[198],"peripheral":[199],"neuropathy":[200],"inconsistent,":[202],"benefit":[205],"acute":[207],"oxaliplatin-related":[208],"neurotoxicity":[209],"insufficient":[211],"support":[212],"prevention":[214],"routine":[216],"chronic":[219],"CIPN.":[220],"other":[223,327],"outcomes,":[226],"oral":[228],"mucositis-associated":[229],"pain,":[230],"fatigue,":[231],"sleep":[232],"quality,":[233],"depressive":[234],"symptoms,":[235],"life,":[239],"limited.":[241],"Venlafaxine":[242,308],"generally":[244],"well":[245],"tolerated,":[246],"although":[247],"adverse":[248],"effects":[249,270],"varied":[250],"by":[251],"dose":[252],"comparator.":[254],"Preclinical":[255],"activity,":[259],"equivalently:":[262],"one":[263],"melanoma":[265],"showed":[267,281],"direct":[268,304],"antiproliferative/pro-apoptotic":[269],"via":[273],"JNK1/2-Nur77":[274],"signaling,":[275],"whereas":[276,321],"colorectal":[278],"study":[280],"only":[282],"context-dependent":[283],"antagonism":[284],"norepinephrine-driven":[286],"tumor":[287],"progression,":[288],"no":[290],"significant":[291],"effect":[292],"alone.":[295],"No":[296],"currently":[299],"supports":[300],"treatment.":[306],"Conclusion:":[307],"an":[310,373],"evidence-based":[312],"its":[322],"CIPN":[325],"uncertain.":[332],"Emerging":[333],"findings":[335],"limited":[337],"considered":[344,368],"hypothesis-generating.":[345],"Further":[346],"randomized":[347],"trials":[349],"needed":[351],"indications,":[355],"while":[356],"additional":[357],"mechanistic":[358],"validation":[361],"is":[362],"required":[363],"before":[364],"can":[366],"evaluation":[371],"therapy.":[375]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2026-10-17T00:00:00"}